FIELD: organic chemistry, steroids, medicine, pharmacy.
SUBSTANCE: invention relates to 3-methylene-steroid derivative of the general formula (1):
wherein R1 means hydrogen atom (H), or in common with R3 it forms β-epoxide; or R1 is absent in the presence of 5-10-double bond; R2 means (C1-C5)-alkyl; R3 means βH, βCH3 or in common with R1 it forms β-epoxide; either R3 is absent in the presence of 5-10-double bond; R4 means hydrogen atom, lower alkyl; Y represents [H, H], [OH, H], [OH, (C2-C5)-alkenyl], [OH, (C2-C5)-alkynyl] or (C1-C6)-alkylidene, or =NOR5 wherein R5 means hydrogen atom (H), lower alkyl; dotted lines represent optional double bond. Compound can relate also to its prodrug used for treatment of arthritis and/or autoimmune diseases.
EFFECT: valuable medicinal properties of compounds, improved method for treatment.
38 cl, 1 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 16-HYDROXY-11-(SUBSTITUTED PHENYL)-ESTRA-4,9-DIENE, COMPOUND, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2187510C2 |
| COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
| STEROID WITH 17-SPIROMETHYLENELACTONE GROUP AND METHOD OF ITS SYNTHESIS | 1995 |
|
RU2168516C2 |
| DERIVATIVE OF 11-(PHENYL-SUBSTITUTED)-ESTRA-4,9-DIENE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2135514C1 |
| 19,11-BRIDGED OVER 4-ESTRENES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS | 1993 |
|
RU2157814C2 |
| PROGESTERONE RECEPTOR MODULATORS | 2005 |
|
RU2381232C2 |
| DERIVATIVES OF 11,21-BISPHENYL-19-NORPREGNANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1995 |
|
RU2152952C2 |
| 18-METHYL-19-NORANDROST-4-ENE-17,17-SPIROETHER (18-METHYL-19-NOR-20-SPIROX-4-EN-3-ON) AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUND | 2007 |
|
RU2440365C2 |
| 17α-ALKYL-17β-HYDROXYESTRATRIENES, THEIR USING AND PHARMACEUTICAL PREPARATION | 2002 |
|
RU2285009C2 |
| 17 β -OXYESTRATRIENES | 2002 |
|
RU2339643C2 |
